Michael Scolaro

Michael Scolaro

Oct 30, 2017

Group 6 Copy 210
4
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Antibiotic Resistance: Between the Environment and Our Bodies

Bacteria have evolved many genes to make them resistant to most of our antibiotics. Such genes can be moved...

Does the Experience of Awe Predict Ketamine's Rapid Antidepressant Effect?

Ketamine is a very rapidly-acting and safe antidepressant medication given as an intravenous infusion, during...

Can albumin from egg whites be used to treat Clostridium difficile infections?

Clostridium difficile infection is a toxin-mediated bacterial infection responsible for 500,000 infections and...

Backer Badge Funded